Sign up to save your podcasts
Or
Share Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
CME credits: 0.25
Valid until: 18-11-2023
Claim your CME credit at https://reachmd.com/programs/cme/direct-from-the-heart-failure-clinic-novel-device-therapy-for-patients-with-hfref/14473/
Despite the use of guideline-directed medical therapy (GDMT), many heart failure (HF) patients may experience worsening symptoms and disease progression. There is now an FDA-approved device that works with GDMT and uses the baroreflex to improve HF-related physiological effects and clinical consequences. Tune in to keep up with baroreflex activation therapy, its mechanism of action, and the associated improved patient outcomes.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 18-11-2023
Claim your CME credit at https://reachmd.com/programs/cme/direct-from-the-heart-failure-clinic-novel-device-therapy-for-patients-with-hfref/14473/
Despite the use of guideline-directed medical therapy (GDMT), many heart failure (HF) patients may experience worsening symptoms and disease progression. There is now an FDA-approved device that works with GDMT and uses the baroreflex to improve HF-related physiological effects and clinical consequences. Tune in to keep up with baroreflex activation therapy, its mechanism of action, and the associated improved patient outcomes.
=